- Home
- CRDF vs GENC Comparison
CRDF vs GENC Comparison
Compare CRDF & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRDF | GENC |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.1M | 205.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CRDF | GENC |
|---|---|---|
| Price | $2.90 | $12.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $10.83 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 28.6K |
| Earning Date | 11-06-2025 | 12-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.92 |
| EPS | N/A | ★ 1.07 |
| Revenue | $501,000.00 | ★ $115,437,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.06 |
| Revenue Growth | N/A | ★ 2.01 |
| 52 Week Low | $1.90 | $10.80 |
| 52 Week High | $4.99 | $18.18 |
Technical Indicators
Market Signals| Indicator | CRDF | GENC |
|---|---|---|
| Relative Strength Index (RSI) | 64.72 | 52.13 |
| Support Level | $2.32 | $12.41 |
| Resistance Level | $3.31 | $13.00 |
| Average True Range (ATR) | 0.17 | 0.51 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 58.41 | 54.63 |
Price Performance
Historical ComparisonAbout CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.